Imperva Inc (NYSE:IMPV) insider Amichai Shulman sold 3,085 shares of the business’s stock in a transaction that occurred on Wednesday, March 15th. The shares were sold at an average price of $41.85, for a total transaction of $129,107.25. Following the sale, the insider now owns 99,151 shares in the company, valued at approximately $4,149,469.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Amichai Shulman also recently made the following trade(s):

  • On Wednesday, February 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $45.91, for a total transaction of $141,632.35.
  • On Tuesday, January 17th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $40.60, for a total transaction of $125,251.00.
  • On Wednesday, December 21st, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $40.00, for a total transaction of $123,400.00.

Imperva Inc (NYSE:IMPV) traded down 0.49% on Monday, reaching $40.90. 295,710 shares of the company’s stock traded hands. The firm’s market cap is $1.37 billion. The stock’s 50 day moving average is $42.91 and its 200 day moving average is $42.15. Imperva Inc has a 52-week low of $31.11 and a 52-week high of $57.24.

Imperva (NYSE:IMPV) last issued its earnings results on Wednesday, February 8th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.29. The company had revenue of $78.40 million for the quarter, compared to analyst estimates of $70.22 million. Imperva had a negative net margin of 25.60% and a negative return on equity of 28.37%. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.20 EPS. On average, equities research analysts predict that Imperva Inc will post $0.33 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

Your IP Address:

A number of research firms have recently issued reports on IMPV. Monness Crespi & Hardt began coverage on shares of Imperva in a report on Tuesday, March 14th. They set a “buy” rating and a $52.00 price target on the stock. Zacks Investment Research upgraded shares of Imperva from a “sell” rating to a “buy” rating and set a $52.00 price objective on the stock in a research note on Tuesday, February 14th. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $55.00 price objective on shares of Imperva in a research note on Friday, February 10th. Imperial Capital upped their price objective on shares of Imperva from $50.00 to $55.00 and gave the company an “outperform” rating in a research note on Friday, February 10th. Finally, Evercore ISI set a $56.00 price objective on shares of Imperva and gave the company a “buy” rating in a research note on Thursday, February 9th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the stock. Imperva has an average rating of “Buy” and a consensus target price of $47.86.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Seven Eight Capital LP acquired a new position in shares of Imperva during the fourth quarter valued at about $207,000. Royal Bank of Canada raised its position in shares of Imperva by 11.4% in the second quarter. Royal Bank of Canada now owns 5,457 shares of the company’s stock valued at $235,000 after buying an additional 558 shares during the period. Ellington Management Group LLC acquired a new position in shares of Imperva during the fourth quarter valued at about $242,000. First Republic Investment Management Inc. raised its position in shares of Imperva by 6.7% in the fourth quarter. First Republic Investment Management Inc. now owns 7,185 shares of the company’s stock valued at $276,000 after buying an additional 453 shares during the period. Finally, A.R.T. Advisors LLC acquired a new position in shares of Imperva during the fourth quarter valued at about $288,000. 92.72% of the stock is currently owned by institutional investors.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.

5 Day Chart for NYSE:IMPV

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.